Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
BLRX
BIOLINERX LTD.
NASDAQ
$2.49
▼ DOWN 1.70% (-0.04)

KEY STATISTICS

Market Cap$10.82 M
52w High$4.56
52w Low$2.15
Dividend Yield—
Frequency—
P/E-1.34
Volume2.55K
Shares Out.4.35M

COMPANY

LEADERSHIP

Philip A. Serlin
CHIEF EXECUTIVE
Philip A. Serlin

ABOUT

SECTOR
Healthcare
WENT PUBLIC
July 27, 2011
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
22

UPCOMING EARNINGS

DateNov 23, 2026
DayMonday
Rev. Est.$357.50K
NOV
23
MON

SPLIT RECORD

DATETYPERATIO
2025-01-30Reverse1:40
2019-07-15Reverse1:15

PRICE

$2.49 ▼ DOWN 1.70% (−$0.04)
OVERLAYS
$2.48$2.55$2.639:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM2.49

About BioLineRx Ltd.

https://www.biolinerx.com ↗

BioLineRx Ltd. is an Israeli clinical-stage biopharma focused on oncology, developing drugs like Motixafortide and AGI-134, with ongoing trials for cancer, respiratory, and skin conditions, and collaborations with MSD and MD Anderson.

INDUSTRY

Biotechnology

A PRODUCT BIOLINERX LTD. IS KNOWN FOR

APHEXDA® (motixafortide)
APHEXDA® (motixafortide)

APHEXDA® (motixafortide) is BioLineRx's FDA-approved injection for stem cell mobilization in multiple myeloma, actively commercialized and being explored for other cancers like pancreatic cancer.

COMPETITORS

COMPETITOR
AMGN COMPARE
SNY COMPARE
XFOR COMPARE

INSTITUTIONAL OWNERSHIP

SHARES OWNED
20.34%
HOLDERS
19
TOP 12 OF 19 · RANKED BY POSITION SIZE
Cvi Holdings, LLC
815.7K sh · $461.68K
Act Capital Management, LLC
27.5K sh · $25K
Xtx Topco Ltd
10.9K sh · $25.27K
Cetera Advisors LLC
10.6K sh · $11.82K
Urban Wealth Management, LLC
9.1K sh · $12K
Next Financial Group, Inc
2.7K sh · $6K
Rhumbline Advisers
2.4K sh · $5.43K
Bnp Paribas Arbitrage, Snc
1.8K sh · $4.14K
Wells Fargo & Company/Mn
1.8K sh · $4.03K
Citigroup Inc
1.7K sh · $3.99K
Ubs Group AG
529 sh · $1.22K
Nemes Rush Group LLC
250 sh · $575

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity1
Return On Assets1
Debt To Equity2
Price To Earnings1
Price To Book4
Overall Score2

INSIDER TRADES

★
DIRECTOR:
Yan Shaoyu
— · —
2026-03-18
★
DIRECTOR
Hofstein Raphael
— · 49.8K shares
2016-10-05
★
DIRECTOR
Hofstein Raphael
— · 199.8K shares
2019-10-02
★
DIRECTOR
Hofstein Raphael
— · 79.8K shares
2020-10-02

SECTORS PEERS

PEERPRICE
ANL$15.74COMPARE
APLM$23.42COMPARE
AIMD$1.48COMPARE
LNAI$2.33COMPARE
ICU$3.54COMPARE
ADTX$0.00COMPARE
MBRX$0.77COMPARE
GOVX$0.36COMPARE